Background Systemic lupus erythematosus (SLE) is an autoimmune disease that typically
affects women aged 16–55 years. Cardiovascular disease (CVD) is a well-recognized …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that primarily affects
young women. Myocardial involvement in SLE frequently occurs and it is rather challenging …

Derangements in the innate and adaptive immune responses observed in systemic
inflammatory syndromes contributes to unique elevated atherosclerotic risk and incident …

Studies on the right ventricular dysfunction (RV) in systemic lupus erythematosus (SLE)
patients are limited, particularly in the pediatric age group. The study aimed to identify …

Cardiovascular diseases (CVDs) are the leading cause of death in chronic inflammatory and
autoimmune rheumatic diseases such as rheumatoid arthritis (RA), systemic lupus …

Systemic lupus erythematous (SLE) is an autoimmune disease with a wide range of
cardiovascular complications. The main manifestations include diseases of the coronary …

Connective tissue diseases (CTDs) can be associated with various forms of pulmonary
hypertension, including pulmonary arterial hypertension (PAH), pulmonary veno‐occlusive …

Left-ventricular assist devices (LVAD) are increasingly used for advanced heart failure [1-7].
LVAD implantation in patients with systemic lupus erythematosus (SLE) appears to be useful …

Aims Epicardial adipose tissue (EAT) has emerged as a mediator between systemic
inflammatory disorders and cardiovascular disease, and may therefore play a role in the …

Background Patients with systemic lupus erythematosus (SLE) have an increased risk of
developing cardiovascular illnesses. Asymptomatic affection might exist, so early diagnosis …